Article Details
Retrieved on: 2018-02-13 09:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Baupost Group</b> LlcMa reported SC 13G/A form with the SEC for Cascadian Therapeutics, Inc. Access it here: 000114036118007143. As reported by Seth Klarman's <b>Baupost Group</b> LlcMa, the filler owns 17.25% or 8,721,079 shares of the Health Care–company. Cascadian Therapeutics, Inc stake is new ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here